Mercury Systems Partners with Flat Medical to Enhance Anesthesia Safety with EpiFaith Syringe
- Flat Medical partners with Mercury Medical to distribute the EpiFaith Smart Syringe in the U.S. anesthesia market.
- Mercury Medical's extensive sales team will enhance the reach of EpiFaith technology among healthcare providers nationwide.
- The collaboration aims to improve patient safety and outcomes in epidural procedures through innovative anesthesia solutions.
Innovative Collaboration Advances Anesthesia Safety Solutions
Flat Medical, a medtech company known for its focus on safety solutions in anesthesia and pain medicine, has solidified a significant partnership with Mercury Medical to distribute its EpiFaith Smart Syringe throughout the U.S. anesthesia market. This agreement marks a pivotal development in the efforts to enhance the safety and efficacy of epidural procedures. The EpiFaith Smart Syringe distinguishes itself by transforming the traditional tactile loss-of-resistance technique into a visual signal, enabling anesthesia providers to more accurately locate the epidural space while ensuring optimal needle control. This innovation significantly reduces the risk of accidental dural punctures and related complications, addressing a critical need in the field of anesthesia.
Mark Rabe, Flat Medical's Director of Sales and Distribution, highlights that this partnership is poised to broaden Flat Medical's reach among healthcare providers across the United States. Leveraging Mercury Medical’s extensive sales team and deep market knowledge will facilitate the delivery of the EpiFaith technology to a wider audience. Mercury Medical, with over six decades of experience in clinical equipment focused on airway management and respiratory support, is well-positioned to introduce this groundbreaking technology to its clientele. The collaboration aims to meet the rising demand for enhanced safety protocols in epidural procedures, which are crucial in labor analgesia, surgical anesthesia, and chronic pain management.
The EpiFaith Smart Syringe has already received notable accolades, including an Innovative Technology contract from Vizient, Inc., and a Technology Breakthrough Designation from Premier, Inc. Its successful application in thousands of clinical epidural placements worldwide underscores its reliability and safety, particularly in obstetric and regional anesthesia settings. By combining Flat Medical's innovative safety technology with Mercury Medical's robust distribution capabilities, this partnership is set to revolutionize the standards of care in anesthesia, ultimately improving patient outcomes and reducing procedural risks.
In addition to this partnership, Mercury Medical's reputation as a leader in clinical equipment enhances its ability to influence the anesthesia market positively. The collaboration signifies an important step towards fostering advancements in medical technology that prioritize patient safety and efficacy in treatment.
The growing partnership landscape in the medtech sector highlights an increasing trend toward innovation and collaboration, aiming to address key challenges in healthcare. As demand for advanced medical solutions continues to rise, strategic alliances like that of Flat Medical and Mercury Medical represent a forward-thinking approach to improving patient care and outcomes in the anesthesia domain.
